Home

Alpa Laboratories Ltd PE Ratio

Image

Alpa Laboratories Ltd

NSE: ALPA

PE

8.9

Last updated on: Mar 16, 2025

Key Highlights

  • The P/E Ratio of Alpa Laboratories Ltd is 8.9 as of 16 Mar 15:29 PM .
  • The P/E Ratio of Alpa Laboratories Ltd changed from 16 on March 2020 to 10.5 on March 2024 . This represents a CAGR of -8.08% over 5 years.
  • The Latest Trading Price of Alpa Laboratories Ltd is ₹ 106.15 as of 13 Mar 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Alpa Laboratories Ltd

No data available

Company Fundamentals for Alpa Laboratories Ltd

Image

Alpa Laboratories Ltd

NSE: ALPA

Share Price

₹ 106.15

2.67 (2.58%)

stock direction

Last updated on: Mar 13, 2025

Market Price of Alpa Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Alpa Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Mar 2025106.15
12 Mar 2025103.48
11 Mar 2025105.42
10 Mar 2025107.92
07 Mar 2025108.67
06 Mar 2025108.74
05 Mar 2025106.59
04 Mar 202597.8
03 Mar 202596.25
28 Feb 202597.95

SWOT Analysis Of Alpa Laboratories Ltd

Strength

4

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Alpa Laboratories Ltd

Asset Value vs Market Value of Alpa Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Alpa Laboratories Ltd223.35
Sun Pharmaceuticals Industries Ltd404012
Divis Laboratories Ltd149188
Cipla Ltd118041
Torrent Pharmaceuticals Ltd103507
Dr Reddys Laboratories Ltd92444

PE Ratio of Alpa Laboratories Ltd Explained

223.35

Market cap

25

Earnings

8.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Alpa Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Alpa Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Alpa Laboratories Ltd

No data available

* All values are in %

About Alpa Laboratories Ltd

  • M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations.
  • In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of 'Alpa Laboratories Limited'.
  • The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh.
  • The unit commenced commercial production in the year 1999 of all types of formulations viz.
  • Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams.

Alpa Laboratories Ltd News Hub

Alpa Laboratories consolidated net profit rises 68.32% in the June 2024 quarter

Net profit of Alpa Laboratories rose 68.32% to Rs 5.10 crore in the quarter ended June 2024 as again

Read more

14 Aug 24

Alpa Laboratories standalone net profit rises 68.98% in the June 2024 quarter

Net profit of Alpa Laboratories rose 68.98% to Rs 5.12 crore in the quarter ended June 2024 as again

Read more

14 Aug 24

Alpa Laboratories to convene board meeting

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po

Read more

05 Aug 24

Alpa Laboratories to conduct AGM

Alpa Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 28

Read more

19 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Alpa Laboratories Ltd

What is the current PE Ratio of Alpa Laboratories Ltd?

The Current PE Ratio of Alpa Laboratories Ltd is 8.85 as on 16 Mar 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 16 Mar 2025.

What was the PE Ratio of Alpa Laboratories Ltd last year?

The PE Ratio of Alpa Laboratories Ltd was 8.99 last year, now the PE ratio is 8.85, showing a year-on-year growth of -1.6%.

What does the PE Ratio of Alpa Laboratories Ltd indicate about its stock?

The PE Ratio of Alpa Laboratories Ltd is 8.85. This ratio indicates that investors are willing to pay 8.85 times the earnings per share for each share of Alpa Laboratories Ltd.

What is the PE Ratio Growth of Alpa Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Alpa Laboratories Ltd grew by -1.6% whereas, the EPS ratio grew by 15.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions